The National Institutes of Health (NIH) are suffering from the general budget crunch. As of
Newsline press time, a budget has not been approved for federal year 2009. The procedure …

The process of diagnosing and treating disease is shifting from a single specialist interacting
with a patient to a multidisciplinary approach that retains a focus on the patient. The focus of …

Significant advances continue in the development of cancerspecific molecular imaging
agents and modalities for diagnosing, staging, and treating various cancer types. For these …

The Highlights Lecture is presented annually at the closing session of the SNM Annual
Meeting by Henry N. Wagner, Jr., MD. This year's lecture, the 29th in the series, was given …

Within the CPI, FDA is pursuing collaborations with multiple parties through effective pooling
of expertise and resources to find constructive and innovative ways of reducing the …

The Molecular Imaging and Contrast Agent Database (MICAD; http://micad. nih. gov)
program has been developed as a key component of the Molecular Imaging Roadmap and …

Yet despite the variety of new methodologies and knowledge being applied to drug
discovery, the number of new chemical entities reaching the market is decreasing: fewer and …

Summary This Special Issue published one editorial, eight articles and four reviews from
approximately one hundred authors. It aimed to provide cutting-edge research on pre …

Abstract The Imaging Probe Development Center (IPDC, Rockville, MD), founded as part of
the 2003 trans-NIH Roadmap for Medical Research initiative, provides synthetic chemistry …

Discussion among summit participants in the Drug Discovery breakout session focused on
identifying challenges and promising strategies for meeting these challenges in the current …